[Federal Register Volume 81, Number 101 (Wednesday, May 25, 2016)]
[Rules and Regulations]
[Pages 33126-33128]
[FR Doc No: 2016-12220]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR part 93

[Docket No.: FAA-2006-25755]

Operating Limitations at New York Laguardia Airport

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Extension to order.

-----------------------------------------------------------------------

SUMMARY: This action extends the Order Limiting Operations at New York
LaGuardia Airport (LGA) published on December 27, 2006, and most
recently extended March 27, 2014. The Order remains effective until
October 27, 2018.

DATES: This action is effective on May 25, 2016.

ADDRESSES: Requests may be submitted by mail to Slot Administration
Office, AGC-240, Office of the Chief Counsel, 800 Independence Avenue
SW., Washington, DC 20591, or by email to<EMAIL_ADDRESS>
FOR FURTHER INFORMATION CONTACT: For questions concerning this Order
contact: Susan Pfingstler, System Operations Services, Air Traffic
Organization, Federal Aviation Administration, 600 Independence Avenue
SW., Washington, DC 20591; telephone<PHONE_NUMBER>; email
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

Availability of Rulemaking Documents

    You may obtain an electronic copy using the Internet by:
    (1) Searching the Federal eRulemaking Portal (http://www.regulations.gov);
    (2) Visiting the FAA's Regulations and Policies Web page at http://www.faa.gov/regulations_policies/; or
    (3) Accessing the Government Printing Office's Web page at http://www.gpoaccess.gov/fr/index.html.
    You also may obtain a copy by sending a request to the Federal
Aviation Administration, Office of Rulemaking, ARM-1, 800 Independence
Avenue SW., Washington, DC 20591, or by calling<PHONE_NUMBER>. Make
sure to identify the amendment number or docket number of this
rulemaking.

Background

    The FAA has long limited the number of arrivals and departures at
LGA during peak demand periods through the implementation of the High
Density Rule (HDR), to address constraints based on LGA's limited
runway capacity.\1\ By statute enacted in April 2000, the HDR's
applicability to LGA operations terminated as of January 1, 2007.\2\
---------------------------------------------------------------------------

    \1\ 33 FR 17896 (Dec. 3, 1968). The FAA codified the rules for
operating at high density traffic airports in 14 CFR part 93,
subpart K. The HDR required carriers to hold a reservation, which
came to be known as a ``slot,'' for each takeoff or landing under
instrument flight rules at the high density traffic airports.
    \2\ Aviation Investment and Reform Act for the 21st Century
(AIR-21), Public Law 106-181 (Apr. 5, 2000), 49 U.S.C. 41715(a)(2).
---------------------------------------------------------------------------

    In anticipation of the HDR's expiration, the FAA proposed a long-
term rule that would limit the number of scheduled and unscheduled
operations at LGA.\3\ The FAA issued an Order on December 27, 2006,
adopting temporary limits pending the completion of the rulemaking.\4\
This Order was amended on November 8, 2007, and August 19, 2008.\5\ On
October 10, 2008, the FAA published the Congestion Management Rule for
LaGuardia Airport, which would have become effective on December 9,
2008.\6\ That rule was stayed by the U.S. Court of Appeals for the
District of Columbia Circuit and subsequently rescinded by the FAA.\7\
The FAA extended the December 27, 2006, Order placing temporary limits
on operations at LGA, as amended, on October 7, 2009,\8\ on April 4,
2011,\9\ on May 14, 2013,\10\ and on March 27, 2014.\11\
---------------------------------------------------------------------------

    \3\ 71 FR 51360 (August 29, 2006); Docket FAA-2006-25709. The
FAA subsequently published a Supplemental Notice of Proposed
Rulemaking. 73 FR 20846 (Apr. 17, 2008).
    \4\ 71 FR 77854.
    \5\ 72 FR 63224; 73 FR 48428.
    \6\ 73 FR 60574, amended by 73 FR 66517 (Nov. 10, 2008).
    \7\ 74 FR 52132 (Oct. 9, 2009).
    \8\ 74 FR 51653.
    \9\ 76 FR 18616, amended by 77 FR 30585 (May 23, 2012).
    \10\ 78 FR 28278.
    \11\ 79 FR 17222.
---------------------------------------------------------------------------

    Under the Order, as amended, the FAA (1) maintains the current
hourly limits on scheduled and unscheduled operations at LGA during the
peak period; (2) imposes an 80 percent minimum usage requirement for
Operating Authorizations (OAs) with defined exceptions; (3) provides a
mechanism for withdrawal of OAs for FAA operational reasons; (4)
provides for a lottery to reallocate withdrawn, surrendered, or
unallocated OAs; and (5) allows for trades and leases of OAs for
consideration for the duration of the Order.
    The reasons for issuing the Order have not changed appreciably
since it was implemented. Runway capacity at LGA remains limited, while
demand for access to LGA remains high and average weekday hourly
flights are generally scheduled to a level consistent with the limits
under this Order. The FAA has reviewed the on-time and other
performance metrics in the peak May to August 2014 and 2015 months and
found continuing improvements relative to the same period in 2007.\12\
Without the operational limitations imposed by this Order, the FAA
expects severe congestion-related delays would occur at LGA and at
other airports throughout the National Airspace System (NAS). The FAA
will continue to monitor performance and runway capacity at LGA to
determine if changes are warranted.
---------------------------------------------------------------------------

    \12\ Docket No. FAA-2006-25755 includes a copy of the MITRE
analysis completed for the FAA.

---------------------------------------------------------------------------

    On January 8, 2015, the DOT and FAA published a notice of proposed
rulemaking ``Slot Management and Transparency at LaGuardia Airport,
John F. Kennedy International Airport, and Newark Liberty International
Airport.'' \13\ The DOT and FAA proposed to replace the Orders limiting
scheduled operations at JFK, limiting scheduled operations at Newark
Liberty International Airport (EWR), and limiting scheduled and
unscheduled operations at LaGuardia Airport (LGA) with a more permanent
system for managing slots. The NPRM included certain proposed changes
to how slots are currently managed in the New York City area in order
to increase transparency and address issues considering anti-
competitive behavior.
---------------------------------------------------------------------------

    \13\ 80 FR 1274.
---------------------------------------------------------------------------

    Since the FAA and DOT first initiated this rulemaking effort there
have been significant changes in circumstances affecting New York City
area airports, including changes in competitive effects from ongoing
industry consolidation, slot utilization and transfer behavior, and
actual operational performance at the three airports. Furthermore, the
FAA recently announced that slot controls are no longer needed at EWR
(81 FR 19861). In light of the changes in market conditions and
operational performance at the New York City area airports, the
Department is withdrawing the NPRM by Federal Register notice published
May 16, 2016 (81 FR 30218), to allow for further evaluation of these
changes.
    Accordingly, the FAA has concluded it is necessary to extend the
expiration date of this Order until October 27, 2018. This expiration
date coincides with the extended expiration date for the Order limiting
scheduled operations at JFK, as also extended by action published in
today's Federal Register.\14\ No amendments other than the expiration
date have been made to this Order.
---------------------------------------------------------------------------

    \14\ The FAA notes that the Order limiting scheduled operations
at EWR will expire October 29, 2016; beginning on October 30, 2016,
EWR is designated a Level 2 schedule-facilitated airport consistent
with the FAA's action published in the Federal Register on April 6,
2016. See id.
---------------------------------------------------------------------------

    The FAA finds that notice and comment procedures under 5 U.S.C.
553(b) are impracticable and contrary to the public interest. The FAA
further finds that good cause exists to make this Order effective in
less than 30 days.

The Amended Order

    In consideration of the foregoing, the Order, as amended, is
recited below in its entirety:

A. Scheduled Operations

    With respect to scheduled operations at LaGuardia:
    1. The final Order governs scheduled arrivals and departures at
LaGuardia from 6 a.m. through 9:59 p.m., Eastern Time, Monday through
Friday and from 12 noon through 9:59 p.m., Eastern Time, Sunday.
Seventy-one (71) Operating Authorizations are available per hour and
will be assigned by the FAA on a 30-minute basis. The FAA will permit
additional, existing operations above this threshold; however, the FAA
will retire Operating Authorizations that are surrendered to the FAA,
withdrawn for non-use, or unassigned during each affected hour until
the number of Operating Authorizations in that hour reaches seventy-one
(71).
    2. The final Order takes effect on January 1, 2007, and will expire
on October 27, 2018.
    3. The FAA will assign operating authority to conduct an arrival or
a departure at LaGuardia during the affected hours to the air carrier
that holds equivalent slot or slot exemption authority under the High
Density Rule of FAA slot exemption rules as of January 1, 2007; to the
primary marketing air carrier in the case of AIR-21 small hub/nonhub
airport slot exemptions; or to the air carrier operating the flights as
of January 1, 2007, in the case of a slot held by a non carrier. The
FAA will not assign operating authority under the final Order to any
person or entity other than a certificated U.S. or foreign air carrier
with appropriate economic authority under 14 CFR part 121, 129 or 135.
The Chief Counsel of the FAA will be the final decision maker regarding
the initial assignment of Operating Authorizations.
    4. For administrative tracking purposes only, the FAA will assign
an identification number to each Operating Authorization.
    5. An air carrier may lease or trade an Operating Authorization to
another carrier for any consideration, not to exceed the duration of
the Order. Notice of a trade or lease under this paragraph must be
submitted in writing to the FAA Slot Administration Office, facsimile
(202) 267-7277 or email<EMAIL_ADDRESS>and must come from a
designated representative of each carrier. The FAA must confirm and
approve these transactions in writing prior to the effective date of
the transaction. However, the FAA will approve transfers between
carriers under the same marketing control up to 5 business days after
the actual operation. This post-transfer approval is limited to
accommodate operational disruptions that occur on the same day of the
scheduled operation.
    6. Each air carrier holding an Operating Authorization must forward
in writing to the FAA Slot Administration Office a list of all
Operating Authorizations held by the carrier along with a listing of
the Operating Authorizations actually operated for each day of the two-
month reporting period within 14 days after the last day of the two-
month reporting period beginning January 1 and every two months
thereafter. Any Operating Authorization not used at least 80 percent of
the time over a two-month period will be withdrawn by the FAA except:
    A. The FAA will treat as used any Operating Authorization held by
an air carrier on Thanksgiving Day, the Friday following Thanksgiving
Day, and the period from December 24 through the first Saturday in
January.
    B. The FAA will treat as used any Operating Authorization obtained
by an air carrier through a lottery under paragraph 7 for the first 120
days after allocation in the lottery.
    C. The Administrator of the FAA may waive the 80 percent usage
requirement in the event of a highly unusual and unpredictable
condition which is beyond the control of the air carrier and which
affects carrier operations for a period of five consecutive days or
more.
    7. In the event that Operating Authorizations are withdrawn for
nonuse, surrendered to the FAA or are unassigned, the FAA will
determine whether any of the available Operating Authorizations should
be reallocated. If so, the FAA will conduct a lottery using the
provisions specified under 14 CFR 93.225. The FAA may retime an
Operating Authorization prior to reallocation in order to address
operational needs. When the final Order expires, any Operating
Authorizations reassigned under this paragraph, except those assigned
to new entrants or limited incumbents, will revert to the FAA for
reallocation according to the reallocation mechanism prescribed in the
final rule that succeeds the final Order.
    8. If the FAA determines that a reduction in the number of
allocated Operating Authorizations is required to meet operational
needs, such as reduced airport capacity, the FAA will conduct a
weighted lottery to withdraw Operating Authorizations to meet a reduced
hourly or half-hourly limit for scheduled operations. The FAA will
provide at least 45 days' notice unless otherwise required by
operational

needs. Any Operating Authorization that is withdrawn or temporarily
suspended will, if reallocated, be reallocated to the air carrier from
which it was taken, provided that the air carrier continues to operate
scheduled service at LaGuardia.
    9. The FAA will enforce the final Order through an enforcement
action seeking a civil penalty under 49 U.S.C. 46301(a). An air carrier
that is not a small business as defined in the Small Business Act, 15
U.S.C. 632, would be liable for a civil penalty of up to $25,000 for
every day that it violates the limits set forth in the final Order. An
air carrier that is a small business as defined in the Small Business
Act would be liable for a civil penalty of up to $10,000 for every day
that it violates the limits set forth in the final Order. The FAA also
could file a civil action in U.S. District Court, under 49 U.S.C.
46106, 46107, seeking to enjoin any air carrier from violating the
terms of the final Order.

B. Unscheduled Operations: \15\
---------------------------------------------------------------------------

    \15\ Unscheduled operations are operations other than those
regularly conducted by an air carrier between LaGuardia and another
service point. Unscheduled operations include general aviation,
public aircraft, military, charter, ferry, and positioning flights.
Helicopter operations are excluded from the reservation requirement.
Reservations for unscheduled flights operating under visual flight
rules (VFR) are granted when the aircraft receives clearance from
air traffic control to land or depart LaGuardia. Reservations for
unscheduled VFR flights are not included in the limits for
unscheduled operators.
---------------------------------------------------------------------------

    With respect to unscheduled flight operations at LaGuardia, the FAA
adopts the following:
    1. The final order applies to all operators of unscheduled flights,
except helicopter operations, at LaGuardia from 6 a.m. through 9:59
p.m., Eastern Time, Monday through Friday and from 12 noon through 9:59
p.m., Eastern Time, Sunday.
    2. The final Order takes effect on January 1, 2007, and will expire
on October 27, 2018.
    3. No person can operate an aircraft other than a helicopter to or
from LaGuardia unless the operator has received, for that unscheduled
operation, a reservation that is assigned by the David J. Hurley Air
Traffic Control System Command Center's Airport Reservation Office
(ARO). Additional information on procedures for obtaining a reservation
will be available via the Internet at http://www.fly.faa.gov/ecvrs.
    4. Three (3) reservations are available per hour for unscheduled
operations at LaGuardia. The ARO will assign reservations on a 30-
minute basis.
    5. The ARO receives and processes all reservation requests.
Reservations are assigned on a ``first-come, first-served'' basis,
determined as of the time that the ARO receives the request. A
cancellation of any reservation that will not be used as assigned would
be required.
    6. Filing a request for a reservation does not constitute the
filing of an instrument flight rules (IFR) flight plan, as separately
required by regulation. After the reservation is obtained, an IFR
flight plan can be filed. The IFR flight plan must include the
reservation number in the ``remarks'' section.
    7. Air Traffic Control will accommodate declared emergencies
without regard to reservations. Nonemergency flights in direct support
of national security, law enforcement, military aircraft operations, or
public use aircraft operations will be accommodated above the
reservation limits with the prior approval of the Vice President,
System Operations Services, Air Traffic Organization. Procedures for
obtaining the appropriate reservation for such flights are available
via the Internet at http://www.fly.faa.gov/ecvrs.
    8. Notwithstanding the limits in paragraph 4, if the Air Traffic
Organization determines that air traffic control, weather, and capacity
conditions are favorable and significant delay is not likely, the FAA
can accommodate additional reservations over a specific period. Unused
operating authorizations can also be temporarily made available for
unscheduled operations. Reservations for additional operations are
obtained through the ARO.
    9. Reservations cannot be bought, sold, or leased.

    Issued in Washington, DC, on May 18, 2016.
Daniel E. Smiley,
Vice President, System Operations Services.
[FR Doc. 2016-12220 Filed 5-24-16; 8:45 am]
BILLING CODE 4910-13-P


[Federal Register Volume 82, Number 116 (Monday, June 19, 2017)]
[Notices]
[Pages 27842-27845]
[FR Doc No: 2017-12600]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2017-N-1315]

Agency Information Collection Activities; Proposed Collection;
Comment Request; Experimental Study of Risk Information Amount and
Location in Direct-to-Consumer Print Ads

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing an
opportunity for public comment on the proposed collection of certain
information by the Agency. Under the Paperwork Reduction Act of 1995
(PRA), Federal Agencies are required to publish notice in the Federal
Register concerning each proposed collection of information and to
allow 60 days for public comment in response to the notice. This notice
solicits comments on research entitled ``Experimental Study of Risk
Information Amount and Location in Direct-to-Consumer Print Ads.'' This
study will examine how repetition and overwarning apply to the
presentation of risks in the context of direct-to-consumer print
advertising.

DATES: Submit either electronic or written comments on the collection
of information by August 18, 2017.

ADDRESSES: You may submit comments as follows. Please note that late,
untimely filed comments will not be considered. Electronic comments
must

be submitted on or before August 18, 2017. The https://www.regulations.gov electronic filing system will accept comments until
midnight Eastern Time at the end of August 18, 2017. Comments received
by mail/hand delivery/courier (for written/paper submissions) will be
considered timely if they are postmarked or the delivery service
acceptance receipt is on or before that date.

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No.
FDA-2017-N-1315 for ``Experimental Study of Risk Information Amount and
Location in Direct-to-Consumer Print Ads.'' Received comments, those
filed in a timely manner (see ADDRESSES) will be placed in the docket
and, except for those submitted as ``Confidential Submissions,''
publicly viewable at https://www.regulations.gov or at the Dockets
Management Staff between 9 a.m. and 4 p.m., Monday through Friday.
     Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: JonnaLynn Capezzuto, Office of
Operations, Food and Drug Administration, Three White Flint North,
10A63, 11601 Landsdown St., North Bethesda, MD 20852,<PHONE_NUMBER>,
<EMAIL_ADDRESS>For copies of the questionnaire contact: Office
of Prescription Drug Promotion (OPDP) Research Team,
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. Background

    Under the PRA (44 U.S.C. 3501-3520), Federal Agencies must obtain
approval from the Office of Management and Budget (OMB) for each
collection of information they conduct or sponsor. ``Collection of
information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and
includes Agency requests or requirements that members of the public
submit reports, keep records, or provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires
Federal Agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information before submitting
the collection to OMB for approval. To comply with this requirement,
FDA is publishing notice of the proposed collection of information set
forth in this document.
    With respect to the following collection of information, FDA
invites comments on these topics: (1) Whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques, when
appropriate, and other forms of information technology.

Experimental Study of Risk Information Amount and Location in Direct-
to-Consumer Print Ads; OMB Control Number 0910--NEW

    Section 1701(a)(4) of the Public Health Service Act (42 U.S.C.
300u(a)(4)) authorizes FDA to conduct research relating to health
information. Section 1003(d)(2)(C) of the Federal Food, Drug, and
Cosmetic Act (the FD&C Act) (21 U.S.C. 393(d)(2)(C)) authorizes FDA to
conduct research relating to drugs and other FDA regulated products in
carrying out the provisions of the FD&C Act.
    Section 502(n) of the FD&C Act (21 U.S.C. 352(n)) specifies that
advertisements (ads) for prescription drugs and biological products
must provide a true statement of information ``in brief summary''
describing the advertised product's ``side effects, contraindications
and effectiveness.'' The prescription drug advertising regulations
provide further clarification on the information to include in brief
summary a true statement of information in brief summary relating to
side effects, contraindications to include side effects, warnings,
precautions, and

contraindications and include any such information under such headings
as cautions, special considerations, important notes, etc. and
effectiveness (21 CFR 202.1(e)(1)). The prescription drug advertising
regulations also specify that the phrase side effect and
contraindication refers to all of the categories of risk information
contained in the required, approved or permitted product labeling
written for health professionals, including the Warnings, Precautions,
and Adverse Reactions sections (21 CFR 202.1(e)(3)(iii)). Ads must also
``present a fair balance between information relating to side effects
and contraindications and effectiveness. . . .'' An ad must present
true information relating to side effects and contraindications in
comparable depth and detail with the claims for effectiveness or safety
(21 CFR 202.1(e)(5)(ii)).
    To fulfill the regulatory requirements for fair balance and the
brief summary, sponsors have typically included risk information about
the product in direct-to-consumer (DTC) print ads both in the main part
of the ad where the product claims appear, and in a separate brief
summary page. The section of the main ad where the risks appear is
often referred to as the ``Important Safety Information'' (ISI).
Including risks in both the ISI and the brief summary may have
advantages. Some research has found that repetition of information
improves recall, especially for older adults (Ref. 1). This might
result in improved recall for risks that appear both in the ISI and
brief summary. However, it is possible that risks appearing on the main
page in the ISI may be more likely to be read than risks appearing in
the brief summary. Based on FDA survey research, about 27 percent of
consumers surveyed in 2002 reported reading half or more of the brief
summary in DTC print ads (Ref. 2). In comparison, when asked how much
of the ``main'' ad they read, about 78 percent reported reading ``all''
or ``almost all'' of the main body portion of the ad.
    One potential downside to including the same warnings in both the
ISI and again in the brief summary is the potential to overwarn
consumers. Overwarning is the concept that individuals are exposed to
so many warnings in the course of daily life that they are less likely
to pay attention to any one particular warning (Ref. 3). In terms of
presenting risk information, detailing too many risks may lead
consumers to discount all risks, or miss the most important risk
information. Similarly, habituation follows when readers see the same
warning repeatedly. Upon seeing a particular warning repeatedly,
consumers may cease to pay attention to it (Refs. 4 to 6). Even if a
warning has features that make it noticeable, it still has the
potential for habituation with repeated exposure (Ref. 5). Although
researchers caution against habituation and overwarning, there appears
to be little empirical research for the logical supposition that seeing
repeated warnings will lead to increased selectivity and reduced
attention by recipients over time. Of note, the Office of Prescription
Drug Promotion (OPDP) is studying the issue of reduced risk information
in the context of DTC TV ads (``Disclosure Regarding Additional Risks
in Direct-to-Consumer Prescription Drug Television Advertisements,''
OMB control number. 0910-0785).
    OPDP plans to investigate, through empirical research, how
repetition and overwarning apply to the presentation of risks in
promotional prescription drug print pieces. We propose to test two
levels of the ISI (short versus long) and the presence of the Brief
Summary (absent versus present) in two different medical conditions
(overactive bladder and rheumatoid arthritis). Figures 1 and 2 describe
the study design. This will be investigated in DTC print ads for
prescription drugs.

                        Figure 1--Study 1 Design
------------------------------------------------------------------------

------------------------------------------------------------------------
                                                         Brief summary
------------------------------------------------------------------------
Rheumatoid Arthritis:
    ISI.............................................       No       Yes
    Short...........................................
    Long............................................
------------------------------------------------------------------------

                        Figure 2--Study 2 Design
------------------------------------------------------------------------

------------------------------------------------------------------------
                                                         Brief summary
------------------------------------------------------------------------
Overactive Bladder:
    ISI.............................................       No       Yes
    Short...........................................
    Long............................................
------------------------------------------------------------------------

    This project is designed to use eye tracking technology to
determine how these risk presentations in DTC print ads are perceived.
Eye tracking technology is an effective method to determine the extent
to which consumers attend to risk information presented in DTC print
ads. This technology allows researchers to unobtrusively detect and
measure where a participant looks while viewing a print ad and for how
long, and the pattern of their eye movements may indicate attention to
and processing of information in the ad.
    We plan to collect descriptive eye tracking data on participants'
attention to the following: (1) The important safety information, (2)
the brief summary, and (3) the indication and benefit claims. All
participants will be 18 years of age or older. We will exclude
individuals who are trained as healthcare professionals, or who work in
pharmaceutical, advertising, or marketing settings because their
knowledge and experiences may not reflect those of the typical
consumer. We will also exclude individuals who have photosensitive
epilepsy; use a medical device that is sensitive to infrared light; or
wear bifocals, hard contact lenses, or colored contact lenses.
    To examine differences between experimental conditions, we will
conduct inferential statistical tests such as analysis of variance
(ANOVA). With the sample size described in this document, we will have
sufficient power to detect small-to-medium sized effects in the main
study.
    We plan to conduct one 60-minute pilot study with 40 participants
and two 60-minute studies with 200 participants each (50 participants
in each cell), for a total of 400 main study participants. The studies
will be conducted in person in at least five different cities across
the United States. The pilot study and main studies will have the same
design and will follow the same procedure. Participants who self-
identify as having one of the medical conditions of interest will be
randomly assigned to one of four test conditions. In Study 1, the ad
will be for a fictitious drug to treat rheumatoid arthritis. In Study
2, the ad will be for a fictitious drug to treat overactive bladder.
After obtaining consent, we will explain the study procedure to
participants and calibrate the eye tracking device. To collect eye
tracking data, we will use an unobtrusive glasses-based real world eye
tracker with a minimum speed of 50 Hertz. The test images will be
presented on paper and sized similarly to how they would appear in
print materials such as magazines. To simulate normal ad viewing,
participants will view two ads. One of the ads will be the study ad.
The non-study ad will be for a consumer product unrelated to health.
Only eye tracking data from the study ad will be analyzed. Next,
participants will complete a questionnaire that assesses risk
perceptions, risk recall, efficacy perceptions, efficacy recall, and
covariates such as demographics and health literacy. In the pilot
study, participants will also answer questions as part of a debriefing
interview to assess the study design and questionnaire.
    FDA estimates the burden of this collection of information as
follows:

                                                      Table 1--Estimated Annual Reporting Burden 1
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                 Number of
                  Activity                       Number of     responses per   Total annual           Average burden per response           Total hours
                                                respondents     respondent       responses
--------------------------------------------------------------------------------------------------------------------------------------------------------
Pilot screener..............................             120               1             120  0.03 (2 minutes)..........................               4
Study 1 screener............................             600               1             600  0.03 (2 minutes)..........................              18
Study 2 screener............................             600               1             600  0.03 (2 minutes)..........................              18
Completes, Pilot............................              40               1              40  1.........................................              40
Completes, Study 1..........................             200               1             200  1.........................................             200
Completes, Study 2..........................             200               1             200  1.........................................             200
                                             -----------------------------------------------------------------------------------------------------------
    Total...................................  ..............  ..............  ..............  ..........................................             480
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.

II. References

    The following references are on display in the Dockets Management
Staff (see ADDRESSES) and are available for viewing by interested
persons between 9 a.m. and 4 p.m., Monday through Friday; they are also
available electronically at https://www.regulations.gov. FDA has
verified the Web site addresses, as of the date this document publishes
in the Federal Register, but Web sites are subject to change over time.

1. McGuire, L.C., ``Remembering What the Doctor Said: Organization
and Older Adults' Memory for Medical Information.'' Experimental
Aging Research, 22, 403-428 (1996).
2. Aikin, K.J., J.L. Swasy, and A.C. Braman, ``Patient and Physician
Attitudes and Behaviors Associated with DTC Promotion of
Prescription Drugs: Summary of FDA Survey Research Results'' (2004).
Available at http://www.fda.gov/downloads/Drugs/ScienceResearch/ResearchAreas/DrugMarketingAdvertisingandCommunicationsResearch/UCM152860.pdf.
3. Warnings and Risk Communication (2005). Wogalter, M.S., D. DeJoy,
and K.R. Laughery (Eds.). Philadelphia: Taylor & Francis, Inc.
4. Conzola, V.C., and M.S. Wogalter, ``A Communication-Human
Information Processing (C-HIP) Approach to Warning Effectiveness in
the Workplace.'' Journal of Risk Research, 4(4), 309-322; (2001).
5. Wogalter, M.S., and K.R Laughery, ``Warning! Sign and Label
Effectiveness.'' Current Directions in Psychological Science, 5(2),
33-37; (1996).
6. Wogalter, M.S., T.L. Smith-Jackson, B.J. Mills, and C.S. Paine,
``The Effects of Print Format in Direct-to-Consumer Prescription
Drug Advertisements on Risk Knowledge and Preference.'' Drug
Information Journal, 36(3), 693-705, 2002.

    Dated: June 13, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning, Legislation, and Analysis.
[FR Doc. 2017-12600 Filed 6-16-17; 8:45 am]
 BILLING CODE 4164-01-P


1 00400 pH S. U. 8/ 4/ 2003 00 9.1 Buckeye Eg2IN00190* A 1 00400 pH S. U. 9/ 8/ 2003 00 7.7 Buckeye Eg2IN00190* A 1 00400 pH S. U. 10/ 6/ 2003 00: 00: 00 AN Buckeye Eg2IN00190* A 1 00400 pH S. U. 11/ 10/ 2003 7.4 Buckeye Eg2IN00190* A 1 00400 pH S. U. 12/ 1/ 2003 0 7.7 Buckeye Eg2IN00190* A 1 00400 pH S. U. 1/ 12/ 2004 0 7.4 Buckeye Eg2IN00190* A 1 00400 pH S. U. 2/ 23/ 2004 0 7.1 Buckeye Eg2IN00190* A 1 00400 pH S. U. 3/ 1/ 2004 00 7.7 Buckeye Eg2IN00190* A 1 00400 pH S. U. 4/ 12/ 2004 0 7.6 Buckeye Eg2IN00190* A 1 00400 pH S. U. 5/ 3/ 2004 00 7.1 Buckeye Eg2IN00190* A 1 00400 pH S. U. 6/ 7/ 2004 00 7.9 Buckeye Eg2IN00190* A 1 00400 pH S. U. 7/ 19/ 2004 0 7.8 Buckeye Eg2IN00190* A 1 00400 pH S. U. 8/ 25/ 2004 0 7.9 Buckeye Eg2IN00190* A 1 00400 pH S. U. 9/ 23/ 2004 0 7.5 Buckeye Eg2IN00190* A 1 00400 pH S. U. 10/ 4/ 2004 0 7.2 Buckeye Eg2IN00190* A 1 00400 pH S. U. 11/ 29/ 2004 7.9 Buckeye Eg2IN00190* A 1 00400 pH S. U. 12/ 8/ 2004 0 8.2 Buckeye Eg2IN00190* A 1 00400 pH S. U. 1/ 10/ 2005 0 7.2 Buckeye Eg2IN00190* A 1 00400 pH S. U. 2/ 15/ 2005 0 7.5 Buckeye Eg2IN00190* A 1 00400 pH S. U. 3/ 1/ 2005 00 7.5 Buckeye Eg2IN00190* A 1 00400 pH S. U. 4/ 6/ 2005 00 7.4 Buckeye Eg2IN00190* A 1 00400 pH S. U. 5/ 4/ 2005 00 7.4 Buckeye Eg2IN00190* A 1 00400 pH S. U. 6/ 8/ 2005 00 8.5 Buckeye Eg2IN00190* A 1 00400 pH S. U. 7/ 18/ 2005 0 6.8 Buckeye Eg2IN00190* A 1 00400 pH S. U. 8/ 10/ 2005 0 7.6 Buckeye Eg2IN00190* A 1 00400 pH S. U. 9/ 6/ 2005 00 8 Buckeye Eg2IN00190* A 1 00400 pH S. U. 10/ 4/ 2005 0 7.6 Buckeye Eg2IN00190* A 1 00400 pH S. U. 11/ 14/ 2005 7.6 Buckeye Eg2IN00190* A 1 00400 pH S. U. 12/ 20/ 2005 7.4 Buckeye Eg2IN00190* A 1 00520 Residue, Vomg/ l 10/ 4/ 2000 0 10.8 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 2/ 12/ 2000 0 26 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 7/ 19/ 2000 0 31 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 8/ 2/ 2000 00 17 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 9/ 6/ 2000 00 29 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 10/ 4/ 2000 0 6 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 11/ 1/ 2000 0 22 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 12/ 6/ 2000 0 69 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 1/ 10/ 2001 0 4 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 2/ 7/ 2001 00 9 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 3/ 21/ 2001 0 21 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 4/ 25/ 2001 0 37 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 5/ 8/ 2001 00 63 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 6/ 13/ 2001 0 91 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 7/ 11/ 2001 0 24 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 8/ 14/ 2001 0 31 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 9/ 27/ 2001 0 27 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 10/ 3/ 2001 0 38 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 11/ 12/ 2001 13 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 12/ 5/ 2001 0 32 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 1/ 28/ 2002 0 9 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 2/ 20/ 2002 0 31 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 3/ 20/ 2002 0 50 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 4/ 10/ 2002 0 48 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 5/ 21/ 2002 0 17 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 6/ 27/ 2002 0 22 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 7/ 16/ 2002 0 32 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 8/ 29/ 2002 0 21 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 10/ 10/ 2002 39 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 11/ 7/ 2002 0 17 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 12/ 1/ 2002 00: 00: 00 AH Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 12/ 5/ 2002 0 28 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 1/ 16/ 2003 0 375 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 2/ 13/ 2003 0 233 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 3/ 18/ 2003 0 13 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 4/ 7/ 2003 00 15 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 5/ 5/ 2003 00 34 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 6/ 9/ 2003 00 43 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 7/ 7/ 2003 00 25 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 8/ 4/ 2003 00 36 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 9/ 8/ 2003 00 10 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 10/ 6/ 2003 0 25 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 11/ 10/ 2003 135 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 12/ 1/ 2003 0 20 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 1/ 12/ 2004 0 87 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 2/ 23/ 2004 00: 00: 00 AH Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 3/ 1/ 2004 00 5 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 4/ 12/ 2004 0 21 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 5/ 3/ 2004 00 12 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 6/ 7/ 2004 00 9 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 7/ 19/ 2004 0 15 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 8/ 25/ 2004 0 9 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 9/ 23/ 2004 0 19 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 10/ 4/ 2004 0 20 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 11/ 29/ 2004 00: 00: 00 AH Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 12/ 8/ 2004 0 13 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 1/ 10/ 2005 0 5 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 2/ 15/ 2005 0 3 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 3/ 1/ 2005 00 19 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 4/ 6/ 2005 00 26 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 5/ 4/ 2005 00 16 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 6/ 8/ 2005 00 48 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 7/ 18/ 2005 0 27 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 8/ 10/ 2005 0 13 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 9/ 6/ 2005 00 16 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 10/ 4/ 2005 0 36 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 11/ 14/ 2005 15 Buckeye Eg2IN00190* A 1 00530 Total Suspemg/ l 12/ 20/ 2005 286 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 2/ 12/ 2000 0 2.27 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 7/ 19/ 2000 0 0.7 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 8/ 2/ 2000 00 3.1 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 9/ 6/ 2000 00 4 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 10/ 4/ 2000 0 2.2 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 11/ 1/ 2000 0 2.1 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 12/ 6/ 2000 0 0.1 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 1/ 10/ 2001 0 6.6 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 2/ 7/ 2001 00 8.3 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 3/ 21/ 2001 0 7.9 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 4/ 25/ 2001 0 3.2 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 5/ 8/ 2001 00 0.1 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 6/ 13/ 2001 0 1.7 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 7/ 11/ 2001 0 0.9 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 8/ 14/ 2001 0 2.6 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 9/ 27/ 2001 0 3.6 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 10/ 3/ 2001 0 0.2 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 11/ 12/ 2001 0.1 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 12/ 5/ 2001 0 0.5 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 1/ 28/ 2002 0 0.1 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 2/ 20/ 2002 0 5.6 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 3/ 20/ 2002 0 7.8 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 4/ 10/ 2002 0 1.2 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 5/ 21/ 2002 0 0.5 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 6/ 27/ 2002 0 0.7 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 7/ 16/ 2002 0 0.1 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 8/ 29/ 2002 0 0.1 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 10/ 10/ 2002 0.9 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 11/ 7/ 2002 0 5.9 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 12/ 1/ 2002 00: 00: 00 AH Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 12/ 5/ 2002 0 0.1 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 1/ 16/ 2003 0 1 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 2/ 13/ 2003 0 3.7 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 3/ 18/ 2003 0 1.1 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 4/ 7/ 2003 00 0.6 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 5/ 5/ 2003 00 0.1 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 6/ 9/ 2003 00 1.5 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 7/ 7/ 2003 00 1.5 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 8/ 4/ 2003 00 2.9 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 9/ 8/ 2003 00 0.4 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 10/ 6/ 2003 0 1.23 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 11/ 10/ 2003 0.7 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 12/ 1/ 2003 0 1.4 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 1/ 12/ 2004 0 1.6 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 2/ 23/ 2004 0 3.9 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 3/ 1/ 2004 00 1.5 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 4/ 12/ 2004 0 0.2 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 5/ 3/ 2004 00 1 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 6/ 7/ 2004 00 0.8 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 7/ 19/ 2004 0 0.4 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 8/ 25/ 2004 0 0.4 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 9/ 23/ 2004 0 1 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 10/ 4/ 2004 0 0.8 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 11/ 29/ 2004 0.1 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 12/ 8/ 2004 0 0.1 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 1/ 10/ 2005 0 0.1 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 2/ 15/ 2005 0 1.4 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 3/ 1/ 2005 00 1.9 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 4/ 6/ 2005 00 0.9 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 5/ 4/ 2005 00 1.6 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 6/ 8/ 2005 00 0.2 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 7/ 18/ 2005 0 0.5 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 8/ 10/ 2005 0 0.5 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 9/ 6/ 2005 00 1 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 10/ 4/ 2005 0 0.1 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 11/ 14/ 2005 0.5 Buckeye Eg2IN00190* A 1 00610 Nitrogen, Amg/ l 12/ 20/ 2005 0.3 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 2/ 12/ 2000 0 11.8 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 7/ 19/ 2000 0 4.35 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 8/ 2/ 2000 00 3.44 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 9/ 6/ 2000 00 1.4 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 10/ 4/ 2000 0 0.1 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 11/ 1/ 2000 0 0.56 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 12/ 6/ 2000 0 0.38 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 1/ 10/ 2001 0 0.96 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 2/ 7/ 2001 00 2.1 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 3/ 21/ 2001 0 2.5 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 4/ 25/ 2001 0 1.1 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 5/ 8/ 2001 00 1 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 6/ 13/ 2001 0 0.91 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 7/ 11/ 2001 0 0.1 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 8/ 14/ 2001 0 2.6 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 9/ 27/ 2001 0 2.2 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 10/ 3/ 2001 0 1.2 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 11/ 12/ 2001 0.02 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 12/ 5/ 2001 0 0.26 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 1/ 28/ 2002 0 0.04 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 2/ 20/ 2002 0 1.7 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 3/ 20/ 2002 0 0.43 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 4/ 10/ 2002 0 4.1 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 5/ 21/ 2002 0 2.4 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 6/ 27/ 2002 0 1.2 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 7/ 16/ 2002 0 0.2 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 8/ 29/ 2002 0 1.3 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 10/ 10/ 2002 0.2 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 11/ 7/ 2002 0 0.4 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 12/ 1/ 2002 00: 00: 00 AH Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 12/ 5/ 2002 0 0.073 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 1/ 16/ 2003 0 0.2 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 2/ 13/ 2003 0 0.9 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 3/ 18/ 2003 0 0.3 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 4/ 7/ 2003 00 0.1 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 5/ 5/ 2003 00 0.14 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 6/ 9/ 2003 00 0.139 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 7/ 7/ 2003 00 0.08 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 8/ 4/ 2003 00 0.08 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 9/ 8/ 2003 00 0.09 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 10/ 6/ 2003 0 2 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 11/ 10/ 2003 0.89 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 12/ 1/ 2003 0 0.05 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 1/ 12/ 2004 0 0.07 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 2/ 23/ 2004 0 0.02 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 3/ 1/ 2004 00 0.01 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 4/ 12/ 2004 0 0.06 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 5/ 3/ 2004 00 0.04 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 6/ 7/ 2004 00 0.01 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 7/ 19/ 2004 0 0.14 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 8/ 25/ 2004 0 0.3 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 9/ 23/ 2004 0 0.05 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 10/ 4/ 2004 0 0.01 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 11/ 29/ 2004 0.01 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 12/ 8/ 2004 0 0.4 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 1/ 10/ 2005 0 0.04 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 2/ 15/ 2005 0 0.01 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 3/ 1/ 2005 00 0.03 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 4/ 6/ 2005 00 0.22 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 5/ 4/ 2005 00 0.13 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 6/ 8/ 2005 00 0.04 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 7/ 18/ 2005 0 0.06 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 8/ 10/ 2005 0 0.05 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 9/ 6/ 2005 00 0.01 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 10/ 4/ 2005 0 0.6 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 11/ 14/ 2005 1.3 Buckeye Eg2IN00190* A 1 00615 Nitrogen, Nmg/ l 12/ 20/ 2005 1.35 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 2/ 12/ 2000 0 0.19 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 7/ 19/ 2000 0 2 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 8/ 2/ 2000 00 0.86 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 9/ 6/ 2000 00 0.11 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 11/ 1/ 2000 0 0.13 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 12/ 6/ 2000 0 3.4 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 1/ 10/ 2001 0 2.44 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 2/ 7/ 2001 00 0.95 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 3/ 21/ 2001 0 0.1 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 4/ 25/ 2001 0 6.3 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 5/ 8/ 2001 00 0.8 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 6/ 13/ 2001 0 1 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 7/ 11/ 2001 0 0.1 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 8/ 14/ 2001 0 6.9 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 9/ 27/ 2001 0 5.9 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 10/ 3/ 2001 0 2.1 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 11/ 12/ 2001 2.4 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 12/ 5/ 2001 0 2.24 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 1/ 28/ 2002 0 2 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 2/ 20/ 2002 0 12.3 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 3/ 20/ 2002 0 12.6 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 5/ 21/ 2002 0 15.6 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 6/ 27/ 2002 0 4.3 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 7/ 16/ 2002 0 0.4 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 8/ 29/ 2002 0 0.1 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 10/ 10/ 2002 10 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 11/ 7/ 2002 0 8.8 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 12/ 1/ 2002 00: 00: 00 AH Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 12/ 5/ 2002 0 11.2 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 1/ 16/ 2003 0 1 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 2/ 13/ 2003 0 9.2 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 3/ 18/ 2003 0 3.3 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 4/ 7/ 2003 00 6.6 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 5/ 5/ 2003 00 2.06 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 6/ 9/ 2003 00 6.74 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 7/ 7/ 2003 00 7.99 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 8/ 4/ 2003 00 0.12 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 9/ 8/ 2003 00 0.21 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 10/ 6/ 2003 0 4.44 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 11/ 10/ 2003 20.3 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 12/ 1/ 2003 0 10.1 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 1/ 12/ 2004 0 6.85 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 2/ 23/ 2004 0 0.24 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 3/ 1/ 2004 00 6.49 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 4/ 12/ 2004 0 9.4 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 5/ 3/ 2004 00 6.13 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 6/ 7/ 2004 00 1.9 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 7/ 19/ 2004 0 1.6 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 8/ 25/ 2004 0 4 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 9/ 23/ 2004 0 0.91 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 10/ 4/ 2004 0 0.3 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 11/ 29/ 2004 0.75 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 12/ 8/ 2004 0 39 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 1/ 10/ 2005 0 0.35 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 2/ 15/ 2005 0 0.71 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 3/ 1/ 2005 00 4.33 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 4/ 6/ 2005 00 11.4 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 5/ 4/ 2005 00 5.92 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 6/ 8/ 2005 00 0.17 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 7/ 18/ 2005 0 0.32 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 8/ 10/ 2005 0 0.33 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 9/ 6/ 2005 00 1.8 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 10/ 4/ 2005 0 0.07 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 11/ 14/ 2005 6.05 Buckeye Eg2IN00190* A 1 00620 Nitrogen, Nmg/ l 12/ 20/ 2005 16 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 2/ 12/ 2000 0 910 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 7/ 19/ 2000 0 118 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 8/ 2/ 2000 00 738 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 9/ 6/ 2000 00 764 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 10/ 4/ 2000 0 478 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 11/ 1/ 2000 00: 00: 00 AA Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 12/ 6/ 2000 0 1.7 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 1/ 10/ 2001 0 299 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 2/ 7/ 2001 00: 00: 00 AA Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 3/ 21/ 2001 0 1.06 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 4/ 25/ 2001 0 3.207 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 5/ 8/ 2001 00 1.025 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 6/ 13/ 2001 0 1234 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 7/ 11/ 2001 00: 00: 00 AA Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 8/ 14/ 2001 00: 00: 00 AA Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 9/ 27/ 2001 0 374 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 10/ 3/ 2001 0 957 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 11/ 12/ 2001 63 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 12/ 5/ 2001 00: 00: 00 AH Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 1/ 28/ 2002 0 441 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 2/ 20/ 2002 0 813 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 3/ 20/ 2002 0 1328 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 4/ 10/ 2002 0 2584 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 5/ 21/ 2002 0 1167 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 6/ 27/ 2002 0 648 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 7/ 16/ 2002 0 120 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 8/ 29/ 2002 0 354 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 10/ 10/ 2002 510 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 11/ 7/ 2002 0 1110 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 12/ 1/ 2002 00: 00: 00 AH Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 12/ 5/ 2002 0 1010 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 1/ 16/ 2003 0 10900 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 2/ 13/ 2003 0 10300 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 3/ 18/ 2003 0 438 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 4/ 7/ 2003 00 788 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 5/ 5/ 2003 00 1390 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 6/ 9/ 2003 00 1280 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 7/ 7/ 2003 00 657 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 8/ 4/ 2003 00 1130 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 9/ 8/ 2003 00 252 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 10/ 6/ 2003 0 565 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 11/ 10/ 2003 2340 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 12/ 1/ 2003 0 1350 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 1/ 12/ 2004 0 1690 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 2/ 23/ 2004 0 636 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 3/ 1/ 2004 00 214 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 4/ 12/ 2004 0 577 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 5/ 3/ 2004 00 433 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 6/ 7/ 2004 00 439 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 7/ 19/ 2004 0 474 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 8/ 25/ 2004 0 355 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 9/ 23/ 2004 0 377 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 10/ 4/ 2004 0 819 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 11/ 29/ 2004 667 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 12/ 8/ 2004 0 1090 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 1/ 10/ 2005 0 8.33 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 2/ 15/ 2005 0 801 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 3/ 1/ 2005 00 705 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 4/ 6/ 2005 00 1090 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 5/ 4/ 2005 00 535 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 6/ 8/ 2005 00 814 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 7/ 18/ 2005 0 781 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 8/ 10/ 2005 0 1121 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 9/ 6/ 2005 00 845 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 10/ 4/ 2005 0 410 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 11/ 14/ 2005 876 Buckeye Eg2IN00190* A 1 00980 Iron, Total Rug/ l 12/ 20/ 2005 1497 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 2/ 12/ 2000 0 10 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 7/ 19/ 2000 0 550 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 8/ 2/ 2000 00 2 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 9/ 6/ 2000 00: 00: 00 AA Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 10/ 4/ 2000 0 3.9 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 11/ 1/ 2000 0 5.5 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 12/ 6/ 2000 00: 00: 00 AA Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 1/ 10/ 2001 0 90 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 2/ 7/ 2001 00: 00: 00 AA Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 3/ 21/ 2001 00: 00: 00 AA Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 4/ 25/ 2001 00: 00: 00 AA Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 5/ 8/ 2001 00 0.043 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 6/ 13/ 2001 0 33 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 7/ 11/ 2001 0 49 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 8/ 14/ 2001 00: 00: 00 AA Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 9/ 27/ 2001 0 39 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 10/ 3/ 2001 0 59 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 11/ 12/ 2001 67 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 12/ 5/ 2001 00: 00: 00 AH Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 1/ 28/ 2002 0 262 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 2/ 20/ 2002 0 48 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 3/ 20/ 2002 0 50 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 4/ 10/ 2002 0 264 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 5/ 21/ 2002 0 114 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 6/ 27/ 2002 0 75 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 7/ 16/ 2002 0 79 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 8/ 29/ 2002 0 261 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 10/ 10/ 2002 73 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 11/ 7/ 2002 0 10 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 12/ 1/ 2002 00: 00: 00 AH Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 12/ 5/ 2002 0 61 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 1/ 16/ 2003 0 204 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 2/ 13/ 2003 0 334 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 3/ 18/ 2003 0 34 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 4/ 7/ 2003 00 32 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 5/ 5/ 2003 00 33 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 6/ 9/ 2003 00 16 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 7/ 7/ 2003 00 187 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 8/ 4/ 2003 00 176 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 9/ 8/ 2003 00 1.1 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 10/ 6/ 2003 0 106 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 11/ 10/ 2003 153 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 12/ 1/ 2003 0 40 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 1/ 12/ 2004 0 61 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 2/ 23/ 2004 0 100 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 3/ 1/ 2004 00 25 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 4/ 12/ 2004 0 25 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 5/ 3/ 2004 00 29 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 6/ 7/ 2004 00 55 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 7/ 19/ 2004 0 36 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 8/ 25/ 2004 0 25 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 9/ 23/ 2004 0 60 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 10/ 4/ 2004 0 102.5 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 11/ 29/ 2004 37 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 12/ 8/ 2004 0 54 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 1/ 10/ 2005 0 282 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 2/ 15/ 2005 0 290 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 3/ 1/ 2005 00 113 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 4/ 6/ 2005 00 207 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 5/ 4/ 2005 00 262 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 6/ 8/ 2005 00 260 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 7/ 18/ 2005 0 381 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 8/ 10/ 2005 0 74 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 9/ 6/ 2005 00 981 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 10/ 4/ 2005 0 1088 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 11/ 14/ 2005 213 Buckeye Eg2IN00190* A 1 01054 Manganeseug/ l 12/ 20/ 2005 6 Buckeye Eg2IN00190* A 901 00310 Biochemicamg/ l 7/ 19/ 2000 0 90 Buckeye Eg2IN00190* A 901 00310 Biochemicamg/ l 2/ 7/ 2001 00 7.3 Buckeye Eg2IN00190* A 901 00310 Biochemicamg/ l 3/ 21/ 2001 00: 00: 00 AH Buckeye Eg2IN00190* A 901 00310 Biochemicamg/ l 4/ 25/ 2001 00: 00: 00 AA Buckeye Eg2IN00190* A 901 00310 Biochemicamg/ l 6/ 13/ 2001 00: 00: 00 AH Buckeye Eg2IN00190* A 901 00310 Biochemicamg/ l 7/ 11/ 2001 00: 00: 00 AH Buckeye Eg2IN00190* A 901 00310 Biochemicamg/ l 12/ 1/ 2001 00: 00: 00 AN Buckeye Eg2IN00190* A 901 00310 Biochemicamg/ l 1/ 28/ 2002 0 1.7 Buckeye Eg2IN00190* A 901 00310 Biochemicamg/ l 4/ 11/ 2002 0 8 Buckeye Eg2IN00190* A 901 00310 Biochemicamg/ l 6/ 1/ 2002 00: 00: 00 AN Buckeye Eg2IN00190* A 901 00310 Biochemicamg/ l 12/ 5/ 2002 00: 00: 00 AH Buckeye Eg2IN00190* A 901 00310 Biochemicamg/ l 1/ 16/ 2003 0 1.4 Buckeye Eg2IN00190* A 901 00310 Biochemicamg/ l 3/ 17/ 2003 00: 00: 00 AH Buckeye Eg2IN00190* A 901 00310 Biochemicamg/ l 8/ 1/ 2005 00 8 Buckeye Eg2IN00190* A 901 00610 Nitrogen, Amg/ l 7/ 19/ 2000 0 0.1 Buckeye Eg2IN00190* A 901 00610 Nitrogen, Amg/ l 2/ 7/ 2001 00 2 Buckeye Eg2IN00190* A 901 00610 Nitrogen, Amg/ l 3/ 21/ 2001 00: 00: 00 AH Buckeye Eg2IN00190* A 901 00610 Nitrogen, Amg/ l 4/ 25/ 2001 0 0.1 Buckeye Eg2IN00190* A 901 00610 Nitrogen, Amg/ l 6/ 13/ 2001 00: 00: 00 AH Buckeye Eg2IN00190* A 901 00610 Nitrogen, Amg/ l 7/ 11/ 2001 00: 00: 00 AH Buckeye Eg2IN00190* A 901 00610 Nitrogen, Amg/ l 12/ 1/ 2001 00: 00: 00 AN Buckeye Eg2IN00190* A 901 00610 Nitrogen, Amg/ l 1/ 28/ 2002 0 0.1 Buckeye Eg2IN00190* A 901 00610 Nitrogen, Amg/ l 4/ 11/ 2002 0 0.7 Buckeye Eg2IN00190* A 901 00610 Nitrogen, Amg/ l 6/ 1/ 2002 00: 00: 00 AN Buckeye Eg2IN00190* A 901 00610 Nitrogen, Amg/ l 12/ 5/ 2002 00: 00: 00 AH Buckeye Eg2IN00190* A 901 00610 Nitrogen, Amg/ l 1/ 16/ 2003 0 0.1 Buckeye Eg2IN00190* A 901 00610 Nitrogen, Amg/ l 3/ 17/ 2003 00: 00: 00 AH Buckeye Eg2IN00190* A 901 00610 Nitrogen, Amg/ l 8/ 2/ 2005 00 0.8 Buckeye Eg2IN00190* A 901 00615 Nitrogen, Nmg/ l 7/ 19/ 2000 0 1.36 Buckeye Eg2IN00190* A 901 00615 Nitrogen, Nmg/ l 2/ 7/ 2001 00 3 Buckeye Eg2IN00190* A 901 00615 Nitrogen, Nmg/ l 3/ 21/ 2001 00: 00: 00 AH Buckeye Eg2IN00190* A 901 00615 Nitrogen, Nmg/ l 4/ 25/ 2001 0 3.3 Buckeye Eg2IN00190* A 901 00615 Nitrogen, Nmg/ l 6/ 13/ 2001 00: 00: 00 AH Buckeye Eg2IN00190* A 901 00615 Nitrogen, Nmg/ l 7/ 11/ 2001 00: 00: 00 AH Buckeye Eg2IN00190* A 901 00615 Nitrogen, Nmg/ l 12/ 1/ 2001 00: 00: 00 AN Buckeye Eg2IN00190* A 901 00615 Nitrogen, Nmg/ l 1/ 28/ 2002 0 0.06 Buckeye Eg2IN00190* A 901 00615 Nitrogen, Nmg/ l 4/ 11/ 2002 0 0.08 Buckeye Eg2IN00190* A 901 00615 Nitrogen, Nmg/ l 6/ 1/ 2002 00: 00: 00 AN Buckeye Eg2IN00190* A 901 00615 Nitrogen, Nmg/ l 12/ 5/ 2002 00: 00: 00 AH Buckeye Eg2IN00190* A 901 00615 Nitrogen, Nmg/ l 1/ 16/ 2003 0 0.02 Buckeye Eg2IN00190* A 901 00615 Nitrogen, Nmg/ l 3/ 17/ 2003 00: 00: 00 AH Buckeye Eg2IN00190* A 901 00615 Nitrogen, Nmg/ l 8/ 4/ 2005 00 0.07 Buckeye Eg2IN00190* A 901 00620 Nitrogen, Nmg/ l 7/ 19/ 2000 0 0.1 Buckeye Eg2IN00190* A 901 00620 Nitrogen, Nmg/ l 2/ 7/ 2001 00 0.25 Buckeye Eg2IN00190* A 901 00620 Nitrogen, Nmg/ l 3/ 21/ 2001 00: 00: 00 AH Buckeye Eg2IN00190* A 901 00620 Nitrogen, Nmg/ l 4/ 25/ 2001 0 0.3 Buckeye Eg2IN00190* A 901 00620 Nitrogen, Nmg/ l 6/ 13/ 2001 00: 00: 00 AH Buckeye Eg2IN00190* A 901 00620 Nitrogen, Nmg/ l 7/ 11/ 2001 00: 00: 00 AH Buckeye Eg2IN00190* A 901 00620 Nitrogen, Nmg/ l 12/ 1/ 2001 00: 00: 00 AN Buckeye Eg2IN00190* A 901 00620 Nitrogen, Nmg/ l 1/ 28/ 2002 0 2.2 Buckeye Eg2IN00190* A 901 00620 Nitrogen, Nmg/ l 4/ 11/ 2002 0 4.9 Buckeye Eg2IN00190* A 901 00620 Nitrogen, Nmg/ l 6/ 1/ 2002 00: 00: 00 AN Buckeye Eg2IN00190* A 901 00620 Nitrogen, Nmg/ l 12/ 5/ 2002 00: 00: 00 AH Buckeye Eg2IN00190* A 901 00620 Nitrogen, Nmg/ l 1/ 16/ 2003 0 3.52 Buckeye Eg2IN00190* A 901 00620 Nitrogen, Nmg/ l 3/ 17/ 2003 00: 00: 00 AH Buckeye Eg2IN00190* A 901 00620 Nitrogen, Nmg/ l 8/ 4/ 2005 00 1.02 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 1/ 1/ 2000 00: 00: 00 AL Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 2/ 16/ 2000 0 0.02 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 3/ 1/ 2000 00: 00: 00 AL Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 4/ 1/ 2000 00: 00: 00 AL Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 5/ 10/ 2000 0 0.17 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 6/ 1/ 2000 00: 00: 00 AL Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 7/ 19/ 2000 0 1 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 8/ 2/ 2000 00 1 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 9/ 20/ 2000 0 2 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 10/ 4/ 2000 0 0.8 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 11/ 1/ 2000 0 0.5 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 12/ 6/ 2000 0 0.1 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 1/ 1/ 2001 00: 00: 00 AL Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 2/ 7/ 2001 00 0.4 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 3/ 21/ 2001 0 0.3 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 4/ 25/ 2001 0 0.6 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 5/ 8/ 2001 00 1.3 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 6/ 13/ 2001 0 3.6 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 7/ 1/ 2001 00: 00: 00 AL Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 7/ 11/ 2001 00: 00: 00 AH Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 8/ 14/ 2001 0 0.8 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 9/ 27/ 2001 0 0.9 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 10/ 17/ 2001 0.9 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 11/ 12/ 2001 0.4 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 12/ 5/ 2001 0 0.4 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 1/ 28/ 2002 0 0.3 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 2/ 20/ 2002 0 0.4 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 3/ 20/ 2002 0 0.4 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 4/ 11/ 2002 0 1 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 5/ 20/ 2002 0 0.7 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 6/ 1/ 2002 00: 00: 00 AL Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 7/ 1/ 2002 00: 00: 00 AL Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 7/ 17/ 2002 00: 00: 00 AL Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 8/ 1/ 2002 00: 00: 00 AL Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 9/ 1/ 2002 00: 00: 00 AL Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 10/ 28/ 2002 2.6 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 11/ 7/ 2002 0 1.4 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 12/ 5/ 2002 0 0.7 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 1/ 16/ 2003 0 0.6 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 2/ 1/ 2003 00: 00: 00 AL Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 3/ 17/ 2003 0 1.1 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 4/ 7/ 2003 00 0.1 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 5/ 5/ 2003 00 3.4 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 6/ 9/ 2003 00 1.4 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 7/ 7/ 2003 00 2 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 8/ 4/ 2003 00 1.3 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 9/ 8/ 2003 00 1.1 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 10/ 6/ 2003 0 1 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 11/ 10/ 2003 0.8 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 12/ 1/ 2003 0 0.2 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 1/ 12/ 2004 0 0.6 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 2/ 23/ 2004 0 2.9 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 3/ 1/ 2004 00 0.1 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 4/ 12/ 2004 0 0.3 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 5/ 3/ 2004 00 0.9 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 6/ 7/ 2004 00 1 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 7/ 19/ 2004 0 0.1 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 8/ 1/ 2004 00: 00: 00 AL Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 9/ 1/ 2004 00: 00: 00 AL Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 10/ 1/ 2004 00: 00: 00 AL Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 11/ 29/ 2004 0.6 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 12/ 7/ 2004 0 1.3 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 1/ 10/ 2005 0 1.4 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 2/ 3/ 2005 00 0.1 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 3/ 1/ 2005 00 1 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 4/ 6/ 2005 00 0.3 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 5/ 4/ 2005 00 0.1 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 6/ 1/ 2005 00: 00: 00 AL Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 7/ 27/ 2005 0 1.2 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 8/ 16/ 2005 0 0.1 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 9/ 6/ 2005 00 0.1 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 10/ 4/ 2005 0 0.81 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 11/ 8/ 2005 0 1 Buckeye Eg2IN00190* A 901 00665 Phosphorusmg/ l 12/ 20/ 2005 0.7 Buckeye Eg2IN00190* A 901 00980 Iron, Total Rug/ l 7/ 19/ 2000 0 335 Buckeye Eg2IN00190* A 901 00980 Iron, Total Rug/ l 3/ 21/ 2001 00: 00: 00 AH Buckeye Eg2IN00190* A 901 00980 Iron, Total Rug/ l 4/ 25/ 2001 00: 00: 00 AA Buckeye Eg2IN00190* A 901 00980 Iron, Total Rug/ l 6/ 13/ 2001 00: 00: 00 AH Buckeye Eg2IN00190* A 901 00980 Iron, Total Rug/ l 7/ 11/ 2001 00: 00: 00 AH Buckeye Eg2IN00190* A 901 00980 Iron, Total Rug/ l 12/ 1/ 2001 00: 00: 00 AN Buckeye Eg2IN00190* A 901 00980 Iron, Total Rug/ l 1/ 28/ 2002 0 215 Buckeye Eg2IN00190* A 901 00980 Iron, Total Rug/ l 4/ 11/ 2002 0 120 Buckeye Eg2IN00190* A 901 00980 Iron, Total Rug/ l 6/ 1/ 2002 00: 00: 00 AN Buckeye Eg2IN00190* A 901 00980 Iron, Total Rug/ l 12/ 5/ 2002 00: 00: 00 AH Buckeye Eg2IN00190* A 901 00980 Iron, Total Rug/ l 1/ 16/ 2003 0 786 Buckeye Eg2IN00190* A 901 00980 Iron, Total Rug/ l 3/ 17/ 2003 00: 00: 00 AH Buckeye Eg2IN00190* A 901 00980 Iron, Total Rug/ l 8/ 3/ 2005 00 963 Buckeye Eg2IN00190* A 901 80508 Triethanolamg/ l 2/ 7/ 2001 00 0.281 Buckeye Eg2IN00190* A 902 00310 Biochemicamg/ l 7/ 19/ 2000 0 70 Buckeye Eg2IN00190* A 902 00310 Biochemicamg/ l 8/ 1/ 2000 00: 00: 00 AY Buckeye Eg2IN00190* A 902 00310 Biochemicamg/ l 2/ 7/ 2001 00: 00: 00 AA Buckeye Eg2IN00190* A 902 00310 Biochemicamg/ l 3/ 21/ 2001 00: 00: 00 AH Buckeye Eg2IN00190* A 902 00310 Biochemicamg/ l 4/ 25/ 2001 00: 00: 00 AA Buckeye Eg2IN00190* A 902 00310 Biochemicamg/ l 6/ 13/ 2001 00: 00: 00 AH Buckeye Eg2IN00190* A 902 00310 Biochemicamg/ l 7/ 11/ 2001 00: 00: 00 AA Buckeye Eg2IN00190* A 902 00310 Biochemicamg/ l 12/ 1/ 2001 00: 00: 00 AN Buckeye Eg2IN00190* A 902 00310 Biochemicamg/ l 1/ 28/ 2002 00: 00: 00 AA Buckeye Eg2IN00190* A 902 00310 Biochemicamg/ l 3/ 1/ 2002 00: 00: 00 AN Buckeye Eg2IN00190* A 902 00310 Biochemicamg/ l 4/ 10/ 2002 0 10 Buckeye Eg2IN00190* A 902 00310 Biochemicamg/ l 11/ 7/ 2002 0 1.4 Buckeye Eg2IN00190* A 902 00310 Biochemicamg/ l 12/ 5/ 2002 00: 00: 00 AH Buckeye Eg2IN00190* A 902 00310 Biochemicamg/ l 1/ 16/ 2003 00: 00: 00 AA Buckeye Eg2IN00190* A 902 00310 Biochemicamg/ l 3/ 17/ 2003 00: 00: 00 AH Buckeye Eg2IN00190* A 902 00310 Biochemicamg/ l 8/ 1/ 2005 00 1 Buckeye Eg2IN00190* A 902 00610 Nitrogen, Amg/ l 7/ 19/ 2000 0 0.1 Buckeye Eg2IN00190* A 902 00610 Nitrogen, Amg/ l 8/ 1/ 2000 00: 00: 00 AY Buckeye Eg2IN00190* A 902 00610 Nitrogen, Amg/ l 2/ 7/ 2001 00 0.1 Buckeye Eg2IN00190* A 902 00610 Nitrogen, Amg/ l 3/ 21/ 2001 00: 00: 00 AH Buckeye Eg2IN00190* A 902 00610 Nitrogen, Amg/ l 4/ 25/ 2001 0 0.1 Buckeye Eg2IN00190* A 902 00610 Nitrogen, Amg/ l 6/ 13/ 2001 00: 00: 00 AH Buckeye Eg2IN00190* A 902 00610 Nitrogen, Amg/ l 7/ 11/ 2001 0 1.7 Buckeye Eg2IN00190* A 902 00610 Nitrogen, Amg/ l 12/ 1/ 2001 00: 00: 00 AN Buckeye Eg2IN00190* A 902 00610 Nitrogen, Amg/ l 1/ 28/ 2002 0 0.1 Buckeye Eg2IN00190* A 902 00610 Nitrogen, Amg/ l 3/ 1/ 2002 00: 00: 00 AN Buckeye Eg2IN00190* A 902 00610 Nitrogen, Amg/ l 4/ 10/ 2002 0 0.3 Buckeye Eg2IN00190* A 902 00610 Nitrogen, Amg/ l 11/ 7/ 2002 0 0.4 Buckeye Eg2IN00190* A 902 00610 Nitrogen, Amg/ l 12/ 5/ 2002 00: 00: 00 AH Buckeye Eg2IN00190* A 902 00610 Nitrogen, Amg/ l 1/ 16/ 2003 0 0.01 Buckeye Eg2IN00190* A 902 00610 Nitrogen, Amg/ l 3/ 17/ 2003 00: 00: 00 AH Buckeye Eg2IN00190* A 902 00610 Nitrogen, Amg/ l 8/ 2/ 2005 00 0.1 Buckeye Eg2IN00190* A 902 00615 Nitrogen, Nmg/ l 7/ 19/ 2000 0 1.04 Buckeye Eg2IN00190* A 902 00615 Nitrogen, Nmg/ l 8/ 1/ 2000 00: 00: 00 AY Buckeye Eg2IN00190* A 902 00615 Nitrogen, Nmg/ l 2/ 7/ 2001 00 3.3 Buckeye Eg2IN00190* A 902 00615 Nitrogen, Nmg/ l 3/ 21/ 2001 00: 00: 00 AH Buckeye Eg2IN00190* A 902 00615 Nitrogen, Nmg/ l 4/ 25/ 2001 0 7.75 Buckeye Eg2IN00190* A 902 00615 Nitrogen, Nmg/ l 6/ 13/ 2001 00: 00: 00 AH Buckeye Eg2IN00190* A 902 00615 Nitrogen, Nmg/ l 7/ 11/ 2001 0 0.01 Buckeye Eg2IN00190* A 902 00615 Nitrogen, Nmg/ l 12/ 1/ 2001 00: 00: 00 AN Buckeye Eg2IN00190* A 902 00615 Nitrogen, Nmg/ l 1/ 28/ 2002 0 0.04 Buckeye Eg2IN00190* A 902 00615 Nitrogen, Nmg/ l 3/ 1/ 2002 00: 00: 00 AN Buckeye Eg2IN00190* A 902 00615 Nitrogen, Nmg/ l 4/ 10/ 2002 0 0.12 Buckeye Eg2IN00190* A 902 00615 Nitrogen, Nmg/ l 11/ 7/ 2002 0 0.037 Buckeye Eg2IN00190* A 902 00615 Nitrogen, Nmg/ l 12/ 5/ 2002 00: 00: 00 AH Buckeye Eg2IN00190* A 902 00615 Nitrogen, Nmg/ l 1/ 16/ 2003 0 0.01 Buckeye Eg2IN00190* A 902 00615 Nitrogen, Nmg/ l 3/ 17/ 2003 00: 00: 00 AH Buckeye Eg2IN00190* A 902 00615 Nitrogen, Nmg/ l 8/ 4/ 2005 00 0.08 Buckeye Eg2IN00190* A 902 00620 Nitrogen, Nmg/ l 7/ 19/ 2000 0 1.47 Buckeye Eg2IN00190* A 902 00620 Nitrogen, Nmg/ l 8/ 1/ 2000 00: 00: 00 AY Buckeye Eg2IN00190* A 902 00620 Nitrogen, Nmg/ l 2/ 7/ 2001 00 0.1 Buckeye Eg2IN00190* A 902 00620 Nitrogen, Nmg/ l 3/ 21/ 2001 00: 00: 00 AH Buckeye Eg2IN00190* A 902 00620 Nitrogen, Nmg/ l 4/ 25/ 2001 0 0.25 Buckeye Eg2IN00190* A 902 00620 Nitrogen, Nmg/ l 6/ 13/ 2001 00: 00: 00 AH Buckeye Eg2IN00190* A 902 00620 Nitrogen, Nmg/ l 7/ 11/ 2001 0 0.01 Buckeye Eg2IN00190* A 902 00620 Nitrogen, Nmg/ l 12/ 1/ 2001 00: 00: 00 AN Buckeye Eg2IN00190* A 902 00620 Nitrogen, Nmg/ l 1/ 28/ 2002 0 2.2 Buckeye Eg2IN00190* A 902 00620 Nitrogen, Nmg/ l 3/ 1/ 2002 00: 00: 00 AN Buckeye Eg2IN00190* A 902 00620 Nitrogen, Nmg/ l 4/ 10/ 2002 0 4.8 Buckeye Eg2IN00190* A 902 00620 Nitrogen, Nmg/ l 11/ 7/ 2002 0 0.2 Buckeye Eg2IN00190* A 902 00620 Nitrogen, Nmg/ l 12/ 5/ 2002 00: 00: 00 AH Buckeye Eg2IN00190* A 902 00620 Nitrogen, Nmg/ l 1/ 16/ 2003 0 0.69 Buckeye Eg2IN00190* A 902 00620 Nitrogen, Nmg/ l 3/ 17/ 2003 00: 00: 00 AH Buckeye Eg2IN00190* A 902 00620 Nitrogen, Nmg/ l 8/ 4/ 2005 00 0.42 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 1/ 1/ 2000 00: 00: 00 AL Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 2/ 16/ 2000 0 0.06 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 3/ 1/ 2000 00: 00: 00 AL Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 4/ 1/ 2000 00: 00: 00 AL Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 5/ 10/ 2000 0 0.05 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 6/ 1/ 2000 00: 00: 00 AL Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 7/ 19/ 2000 0 0.1 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 8/ 2/ 2000 00 2.8 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 9/ 6/ 2000 00 0.7 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 10/ 4/ 2000 0 0.4 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 11/ 1/ 2000 0 0.3 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 12/ 6/ 2000 0 0.1 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 1/ 10/ 2001 0 0.4 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 2/ 7/ 2001 00 0.1 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 3/ 21/ 2001 0 0.1 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 4/ 25/ 2001 0 0.5 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 5/ 8/ 2001 00 0.2 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 6/ 13/ 2001 0 0.3 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 7/ 11/ 2001 0 0.4 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 8/ 14/ 2001 0 0.4 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 9/ 27/ 2001 0 0.4 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 10/ 3/ 2001 0 0.1 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 11/ 12/ 2001 0.1 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 12/ 5/ 2001 0 0.4 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 1/ 28/ 2002 0 0.1 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 2/ 20/ 2002 0 0.1 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 3/ 20/ 2002 0 0.1 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 4/ 10/ 2002 0 1.3 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 5/ 20/ 2002 0 0.1 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 6/ 27/ 2002 0 0.1 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 7/ 17/ 2002 0 365.4 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 8/ 1/ 2002 00: 00: 00 AL Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 9/ 1/ 2002 00: 00: 00 AL Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 10/ 1/ 2002 00: 00: 00 AL Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 11/ 7/ 2002 0 0.3 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 12/ 5/ 2002 0 0.5 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 1/ 16/ 2003 0 0.1 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 2/ 27/ 2003 0 1.3 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 3/ 17/ 2003 0 0.7 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 4/ 7/ 2003 00 0.1 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 5/ 5/ 2003 00 1.7 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 6/ 9/ 2003 00 1.3 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 7/ 7/ 2003 00 1.4 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 8/ 4/ 2003 00 0.3 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 9/ 8/ 2003 00 0.4 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 10/ 6/ 2003 0 0.4 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 11/ 10/ 2003 0.2 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 12/ 1/ 2003 0 0.04 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 1/ 12/ 2004 0 0.2 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 2/ 23/ 2004 0 0.9 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 3/ 1/ 2004 00 0.1 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 4/ 12/ 2004 0 0.3 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 5/ 3/ 2004 00 0.9 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 6/ 7/ 2004 00 1.2 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 7/ 19/ 2004 0 0.1 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 8/ 25/ 2004 0 1.1 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 9/ 23/ 2004 0 0.5 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 10/ 4/ 2004 0 0.1 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 11/ 29/ 2004 0.8 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 12/ 7/ 2004 0 1.7 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 1/ 10/ 2005 0 3.2 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 2/ 3/ 2005 00 0.1 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 3/ 1/ 2005 00 1.6 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 4/ 6/ 2005 00 0.5 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 5/ 4/ 2005 00 0.2 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 6/ 8/ 2005 00 0.2 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 7/ 27/ 2005 0 2.2 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 8/ 10/ 2005 0 0.1 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 9/ 6/ 2005 00 0.1 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 10/ 4/ 2005 0 0.93 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 11/ 8/ 2005 0 0.8 Buckeye Eg2IN00190* A 902 00665 Phosphorusmg/ l 12/ 20/ 2005 0.1 Buckeye Eg2IN00190* A 902 00980 Iron, Total Rug/ l 7/ 19/ 2000 0 104 Buckeye Eg2IN00190* A 902 00980 Iron, Total Rug/ l 8/ 1/ 2000 00: 00: 00 AY Buckeye Eg2IN00190* A 902 00980 Iron, Total Rug/ l 3/ 21/ 2001 00: 00: 00 AH Buckeye Eg2IN00190* A 902 00980 Iron, Total Rug/ l 4/ 25/ 2001 0 1.15 Buckeye Eg2IN00190* A 902 00980 Iron, Total Rug/ l 6/ 13/ 2001 00: 00: 00 AH Buckeye Eg2IN00190* A 902 00980 Iron, Total Rug/ l 7/ 11/ 2001 00: 00: 00 AA Buckeye Eg2IN00190* A 902 00980 Iron, Total Rug/ l 12/ 1/ 2001 00: 00: 00 AN Buckeye Eg2IN00190* A 902 00980 Iron, Total Rug/ l 1/ 28/ 2002 0 157 Buckeye Eg2IN00190* A 902 00980 Iron, Total Rug/ l 3/ 1/ 2002 00: 00: 00 AN Buckeye Eg2IN00190* A 902 00980 Iron, Total Rug/ l 4/ 10/ 2002 0 6141 Buckeye Eg2IN00190* A 902 00980 Iron, Total Rug/ l 11/ 7/ 2002 0 691 Buckeye Eg2IN00190* A 902 00980 Iron, Total Rug/ l 12/ 5/ 2002 00: 00: 00 AH Buckeye Eg2IN00190* A 902 00980 Iron, Total Rug/ l 1/ 16/ 2003 0 347 Buckeye Eg2IN00190* A 902 00980 Iron, Total Rug/ l 3/ 17/ 2003 00: 00: 00 AH Buckeye Eg2IN00190* A 902 00980 Iron, Total Rug/ l 8/ 3/ 2005 00 6449 Buckeye Eg2IN00190* A 902 80508 Triethanolamg/ l 2/ 7/ 2001 00 0.266 mdl


[Federal Register Volume 87, Number 102 (Thursday, May 26, 2022)]
[Notices]
[Pages 32016-32017]
[FR Doc No: 2022-11353]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPPT-2021-0303; 9890-01-OMS]

Information Collection Request Submitted to OMB for Review and
Approval; Comment Request; Methylene Chloride; Regulation of Paint and
Coating Removal for Consumer Use Under TSCA Section 6(a) (Renewal)

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Environmental Protection Agency (EPA) has submitted an
information collection request (ICR), ``Methylene Chloride; Regulation
of Paint and Coating Removal for Consumer Use under Toxic Substances
Control Act (TSCA) Section 6(a),'' (EPA ICR Number 2556.03, OMB Control
Number 2070-0204) to the Office of Management and Budget (OMB) for
review and approval in accordance with the Paperwork Reduction Act.
This is a proposed extension of the ICR, which is currently approved
through May 31, 2022. Public comment were previously requested via the
Federal Register on August 31, 2021 during a 60-day comment period.
This notice allows for an additional 30 days for public comment. A
fuller description of the ICR is given below, including its estimated
burden and cost to the public. An agency may not conduct or sponsor and
a person is not required to respond to a collection of information
unless it displays a currently valid OMB control number.

DATES: Comments must be received on or before June 27, 2022.

ADDRESSES: Submit your comments to EPA, referencing Docket ID No.: EPA-
HQ-OPPT-2021-0303, online using www.regulations.gov (our preferred
method) or by mail to: EPA Docket Center, Environmental Protection
Agency, Mail Code 28221T, 1200 Pennsylvania Ave. NW, Washington, DC
20460. EPA's policy is that all comments received will be included in
the public docket without change including any personal information
provided, unless the comment includes profanity, threats, information
claimed to be Confidential Business Information (CBI), or other
information whose disclosure is restricted by statute.
    Submit written comments and recommendations to OMB for the proposed
information collection within 30 days of publication of this notice to
www.reginfo.gov/public/do/PRAMain. Find this particular information
collection by selecting ``Currently under 30-day Review--Open for
Public Comments'' or by using the search function.

FOR FURTHER INFORMATION CONTACT: Katherine Sleasman, Regulatory Support
Branch (7101M), Office of Chemical Safety and Pollution Prevention,
Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington,
DC 20460-0001; telephone number:<PHONE_NUMBER>; email address:
[email protected].

SUPPLEMENTARY INFORMATION: Supporting documents, which explain in
detail the information that the EPA will be collecting, are available
in the public docket for this ICR. The docket can be viewed online at
www.regulations.gov or in person at the EPA Docket Center, WJC West,
Room 3334, 1301 Constitution Ave. NW, Washington, DC. The telephone
number for the Docket Center is<PHONE_NUMBER>. For additional
information about EPA's public docket, visit http://www.epa.gov/dockets.
    Abstract: The manufacture, processing, and distribution in commerce
of methylene chloride for consumer paint and coating removal is
prohibited under EPA regulations in 40 CFR part 751, as promulgated
under the TSCA, 15. U.S.C. 2601 et seq. Manufacturers, processors, or
distributers in commerce for non-prohibited uses are required to notify
companies to whom methylene chloride is shipped of the prohibitions
under 40 CFR 751 through the Safety Data Sheet

(SDS). It also requires manufacturers, processors, or distributers in
commerce (except for retailers) to retain methylene chloride in one
location at the headquarters of the company, or the facility for which
the records were generated, documentation showing: (i) The name,
address, contact, and telephone number of companies to whom methylene
chloride was shipped; (ii) a copy of the notification provided to
companies to whom the methylene chloride was shipped; and (iii) the
amount of methylene chloride shipped. This information must be retained
for three years from the date of shipment. EPA established these
requirements under TSCA Section 6(a) in response to a final
determination that the consumer use of paint and coating removal
presents an unreasonable risk of injury to health. This ICR consists of
the downstream notification of the prohibitions and the recordkeeping
requirement.
    Form Numbers: None.
    Respondents/affected Entities: Respondents affected by this
activity may include those that engage in the manufacture, processing
and distribution in commerce of methylene chloride for consumer paint
and coating removal. The ICR provides a list of the North American
Industrial Classification System codes that might apply to entities
that may be affected by the activities described in this ICR.
    Respondent's obligation to respond: Mandatory per 40 CFR 751 and
TSCA section 6(a).
    Frequency of response: On occasion.
    Estimated number of potential respondents: 14 (total).
    Total Estimated burden: 7 hours (per year). Burden is defined at 5
CFR 1320.03(b).
    Total estimated cost: $298 (per year), which includes no annualized
capital or operation & maintenance costs.
    Changes in the estimates: There is a decrease in the estimated
total annual burden and costs compared with that identified in the ICR
currently approved by OMB. Burden decreased from 69 hours to 7 hours.
This decrease is due a decrease in the number of respondents.

Courtney Kerwin,
Director, Regulatory Support Division, Office of Mission Support.
[FR Doc. 2022-11353 Filed 5-25-22; 8:45 am]
BILLING CODE 6560-50-P